These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 9483747

  • 21. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G.
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [Abstract] [Full Text] [Related]

  • 22. [Genetic marking of polyresistant mycobacterium tuberculosis strains isolated in the north-west of Russia].
    Narvskaia OV, Mokrousov IV, Otten TF, Vishnevskiĭ BI.
    Probl Tuberk; 1999 May; (3):39-41. PubMed ID: 10420767
    [Abstract] [Full Text] [Related]

  • 23. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA, Ismailov ShSh, Berikova EM.
    Probl Tuberk; 2000 May; (3):23-5. PubMed ID: 10900979
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pulmonary tuberculosis in diabetes mellitus.
    Doost JY, Vessal K.
    Trop Geogr Med; 1975 Dec; 27(4):351-3. PubMed ID: 1216313
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rüsch-Gerdes S, Blok L, Doshetov D.
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Course of pulmonary tuberculosis in diabetics].
    Mboussa J, Monabeka H, Kombo M, Yokolo D, Yoka-Mbio A, Yala F.
    Rev Pneumol Clin; 2003 Feb; 59(1):39-44. PubMed ID: 12717325
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D, Seyoum B, Makonnen E, Atsebeha H, Woldemeskel D, Yamuah L, Addus H, Aseffa A.
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [Abstract] [Full Text] [Related]

  • 35. [Characteristics of the course of destructive pulmonary tuberculosis with L-forms of mycobacteria in the sputum].
    Golanov VS.
    Vrach Delo; 1981 Aug; (8):79-81. PubMed ID: 6791384
    [No Abstract] [Full Text] [Related]

  • 36. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R, Al-Sharif N, Al-Sayegh MO, Osman MM, Shaikh MA.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [Abstract] [Full Text] [Related]

  • 37. [Multi-drug resistant lung tuberculosis due to double infection of MDR strain].
    Ito K, Takahashi M, Yoshiyama T, Wada M, Ogata H.
    Kekkaku; 2004 Jun; 79(6):387-90. PubMed ID: 15293752
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Effectiveness of the standard mode of chemotherapy for newly-diagnosed patients with destructive pulmonary tuberculosis with bacterial isolation].
    Mishin VIu, Chukanov VI, Vylegzhanin SV.
    Probl Tuberk; 2001 Jun; (7):13-8. PubMed ID: 11763553
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.